Indira Brar

8PUBLICATIONS
32CO-AUTHORS
Disease surveillanceRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 14, 2026
Implementation of a Best Practice Advisory-Based HIV Screening Program in the Emergency Department with Integrated Infectious Diseases: A Descriptive Study.

|May 25, 2026
Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b Clinical Trials.

|Jul 03, 2025
Assessment of Failures of Long-acting Cabotegravir and Rilpivirine in a Real-world Treatment Setting.

Nicholas Yared, Smitha Gudipati, Shannon Payne

|Apr 10, 2025
Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort.

Emma Davies Smith, Carlos Malvestutto, Heather J Ribaudo

|Feb 24, 2025
Efficacy and safety of switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir/abacavir/lamivudine: Results from an open-label extension of a phase 3 randomized, double-blind, multicenter, active-controlled, non-inferiority study.

Indira Brar, Peter J Ruane, Mezgebe Berhe

|Jul 13, 2022
Progression to Critical Illness and Death in Patients With Breakthrough Hospitalizations.

Geehan Suleyman, Raef Fadel, Ayman Alsaadi

Pageof 2

Frequent Collaborators

2 joint publications

Joseph Miller

2 joint publications

Mayur Ramesh

2 joint publications

Shannon Payne

2 joint publications

Smitha Gudipati